Details of the Drug Reposition

General Information of This Drug (ID: DM11R0Z)

Drug Name
CHS-0214   DM11R0Z

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ischemic heart disease DISXQ6WJ BA40-BA6Z Phase 3 [1]
Plaque psoriasis DISQX1LF EA90.0 Phase 3 [2]
Rheumatoid arthritis DISTSB4J FA20 Phase 3 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02115750) Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)